1. Home
  2. ELDN vs FET Comparison

ELDN vs FET Comparison

Compare ELDN & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • FET
  • Stock Information
  • Founded
  • ELDN 2004
  • FET 2005
  • Country
  • ELDN United States
  • FET United States
  • Employees
  • ELDN N/A
  • FET N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • FET Metal Fabrications
  • Sector
  • ELDN Health Care
  • FET Industrials
  • Exchange
  • ELDN Nasdaq
  • FET Nasdaq
  • Market Cap
  • ELDN 178.4M
  • FET 187.2M
  • IPO Year
  • ELDN N/A
  • FET 2012
  • Fundamental
  • Price
  • ELDN $3.06
  • FET $14.85
  • Analyst Decision
  • ELDN Strong Buy
  • FET
  • Analyst Count
  • ELDN 1
  • FET 0
  • Target Price
  • ELDN $16.00
  • FET N/A
  • AVG Volume (30 Days)
  • ELDN 214.2K
  • FET 47.3K
  • Earning Date
  • ELDN 05-14-2025
  • FET 05-01-2025
  • Dividend Yield
  • ELDN N/A
  • FET N/A
  • EPS Growth
  • ELDN N/A
  • FET N/A
  • EPS
  • ELDN N/A
  • FET N/A
  • Revenue
  • ELDN N/A
  • FET $807,312,000.00
  • Revenue This Year
  • ELDN N/A
  • FET N/A
  • Revenue Next Year
  • ELDN N/A
  • FET $1.72
  • P/E Ratio
  • ELDN N/A
  • FET N/A
  • Revenue Growth
  • ELDN N/A
  • FET 7.31
  • 52 Week Low
  • ELDN $2.30
  • FET $12.78
  • 52 Week High
  • ELDN $5.54
  • FET $21.57
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 49.05
  • FET 47.43
  • Support Level
  • ELDN $2.96
  • FET $14.52
  • Resistance Level
  • ELDN $3.27
  • FET $15.09
  • Average True Range (ATR)
  • ELDN 0.17
  • FET 0.60
  • MACD
  • ELDN 0.02
  • FET 0.04
  • Stochastic Oscillator
  • ELDN 53.33
  • FET 26.77

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

Share on Social Networks: